Drug-Drug Interaction Study: ASP2151 and Midazolam

NCT02403635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Midazolam
DRUG: ASP2151

Sponsor

Maruho Europe Limited